Multiplex Assay Kit for VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay)

NERP1; NERP2; Neuro-Endocrine Specific Protein VGF; Neuroendocrine Regulatory Peptide

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 85-94 90
EDTA plasma(n=5) 96-104 101
heparin plasma(n=5) 96-104 101
sodium citrate plasma(n=5) 78-95 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-91% 80-90% 94-101% 86-95%
EDTA plasma(n=5) 97-105% 86-97% 81-93% 78-93%
heparin plasma(n=5) 79-97% 82-93% 78-98% 99-105%
sodium citrate plasma(n=5) 84-92% 86-94% 98-105% 80-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:VGF) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Neuroendocrinology Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity PubMed: 22296024
J Psychiatr Res Low VGF is associated with executive dysfunction in patients with major depressive disorder Pubmed:35738161
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APB166Hu61 Active VGF Nerve Growth Factor Inducible (VGF) Cell culture; Activity Assays.
EPB166Hu62 Eukaryotic VGF Nerve Growth Factor Inducible (VGF) Positive Control; Immunogen; SDS-PAGE; WB.
APB166Hu02 Active VGF Nerve Growth Factor Inducible (VGF) Cell culture; Activity Assays.
APB166Hu01 Active VGF Nerve Growth Factor Inducible (VGF) Cell culture; Activity Assays.
EPB166Hu61 Eukaryotic VGF Nerve Growth Factor Inducible (VGF) Positive Control; Immunogen; SDS-PAGE; WB.
RPB166Hu02 Recombinant VGF Nerve Growth Factor Inducible (VGF) Positive Control; Immunogen; SDS-PAGE; WB.
RPB166Hu01 Recombinant VGF Nerve Growth Factor Inducible (VGF) Positive Control; Immunogen; SDS-PAGE; WB.
PAB166Hu01 Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB; IHC; ICC; IP.
LAB166Hu71 Biotin-Linked Polyclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB; IHC; ICC.
MAB166Hu22 Monoclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB,IHC
MAB166Hu21 Monoclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB; IHC; ICC; IP.
MAB166Hu23 Monoclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB; IHC; ICC; IP.
MAB166Hu24 Monoclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB; IHC; ICC; IP.
MAB166Hu25 Monoclonal Antibody to VGF Nerve Growth Factor Inducible (VGF) WB; IHC; ICC; IP.
SEB166Hu ELISA Kit for VGF Nerve Growth Factor Inducible (VGF) Enzyme-linked immunosorbent assay for Antigen Detection.
HEB166Hu High Sensitive ELISA Kit for VGF Nerve Growth Factor Inducible (VGF) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB166Hu Multiplex Assay Kit for VGF Nerve Growth Factor Inducible (VGF) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.